Status:
UNKNOWN
A Comparison of Thoracic Electrical Bioimpedance and FloTrac/Vigileo
Lead Sponsor:
RenJi Hospital
Conditions:
Stroke Volume Variation
SVV-FloTrac
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Stroke volume variation (SVV) is an indicator used to assess the patient's volume status. The FloTrac system (Edwards Lifesciences, Irvine, CA) continuously monitors cardiac output (CO) and SVV (SVV-F...
Eligibility Criteria
Inclusion
- Age 18≤ Age ≤65.
- patients undergoinglaparoscopic elective surgery for gastrointestinal tumors under general anesthesia
- 18 kg/m2≤BMI≤30 kg/m2
- ASA classification I-III
- Patients signed informed consent form
Exclusion
- Arrhythmias
- The patient is diagnosed with severe cardiovascular disease（pulmonary arterial hypertension、left ventricular ejection fraction\< 50%、aortic aneurysm、extensive peripheral arterial occlusive disease,、significant valvulopathy）
- Severe heart failure (METS\<4)
- The patient is diagnosed with severe hepatic dysfunction (ChildePugh class C)
- The patient is diagnosed with severe renal dysfunction (undergoing dialysis before surgery)
- There is an infectious lesion on the skin or subcutaneous tissue where the non-invasive electrode piece is placed
- History of allergy to anesthetic drugs
- Weight\<40kg
- Allergies to 6% hydroxyethyl starch, Fresenius Kabi, Deutschland
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06143111
Start Date
November 20 2023
End Date
December 31 2025
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital, Shanghai Jiaotong University School of Medicine
Pudong, Shanghai Municipality, China, 200127